Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,872.16
      -2.95%
      US Tech 100
      20,616.80
      -3.80%
      Dow Jones
      42,326.87
      -2.58%
      Brent Oil
      72.615
      -0.67%
      Bitcoin
      100,930.35
      -4.92%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Arcturus Therapeutics Holdings Inc (ARCT)

      7. Arcturus Therapeutics Holdings Inc (ARCT) Financials

      Arcturus Therapeutics Holdings Inc

      Arcturus Therapeutics Holdings Inc (ARCT)

      NASDAQ
      14.82
      -0.91
      (-5.79%)
      At close: December 18 4:00PM
      Delayed by 15 minutes
      14.82
      0.00
      ( 0.00% )
      After Hours: 4:30PM
      Delayed by 15 minutes

      Arcturus Therapeutics Holdings Inc Financial Summary

      The current ARCT market cap is 401.43M. The company's latest EPS is USD -1.0974 and P/E is -13.51.

      Income Statement

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 45.14M33.99M38.01M49.86M41.67M
      Operating Income -18M-15.14M-30.41M-21.13M-10.74M
      Net Income 1.66M-8.57M-26.82M-17.22M-6.9M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Revenue 20.79M9.54M12.36M206M166.8M
      Operating Income -25.55M-71.79M-202.34M11.66M-78.21M
      Net Income -25.99M-72.15M-203.67M9.35M-29.73M

      Balance Sheet

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 457.65M429.4M418.85M388.61M370.65M
      Total Liabilities 177.59M147.76M154.88M130.03M108.79M
      Total Equity 280.06M281.65M263.97M258.58M261.87M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Total Assets 82.14M476.46M392.81M450.39M429.4M
      Total Liabilities 56.35M79.9M164.6M180.08M150.89M
      Total Equity 25.79M396.55M228.21M270.31M278.51M

      Cash Flow

      Annual Quarterly
      Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -17.47M N/A -5.56M-35.7M-59.46M
      Investing -2.03M N/A -240k-568k-648k
      Financing -5.43M N/A 2.19M4.59M5.28M
      Year End December 30 2023 20192020202120222023
      USD ($)USD ($)USD ($)USD ($)USD ($)
      Operating -6.45M-42.86M-135.04M31.99M-18.1M
      Investing -818k-1.74M-3.41M-7.73M-2.9M
      Financing 41.91M436.15M48.02M-2.86M-24.09M

      Stats and Ratios

      Market Cap 401.43M
      Price to Earnings Ratio -13.51
      Price to Sales Ratio 2.41
      Price to Cash Ratio 1.38
      Price to Book Ratio 1.44
      Dividend Yield -

      Share Statistics

      Shares Outstanding 27.09M
      Average Volume (1 week) 355.68k
      Average Volume (1 Month) 367.29k
      52 Week Change -48.74%
      52 Week High 45.00
      52 Week Low 14.83
      Spread (Intraday) 0.76 (4.88%)

      Company Info

      Company Name Arcturus Therapeutics Holdings Inc
      Address 10628 science center drive, suite 250
      san diego, california 92121
      Website https://arcturusrx.com
      Industry pharmaceutical preparations (2834)